Granules is granulating the speed process #SuperChartz

Key Levels:

Support: 408

Resistance 450, 520, 650

Key Drivers:

Granules India is a pharmaceutical company with a market capitalization of ₹10,876 crore. Its current stock price stands at ₹449, with a high/low range of ₹453/₹268. The stock has a P/E ratio of 27.6 and a price-to-book value of 3.65. Its EPS is ₹16.3, and it offers a dividend yield of 0.34%. The company has shown robust returns with a 16.9% return over 3 months and a 7.49% return over 3 years. Granules India maintains strong financial health with an ROE and ROCE of 19.1% and 19.4% respectively. It has a healthy current ratio of 1.35 and a debt-to-equity ratio of 0.47. The company's OPM stands at 18.3%, with sales totaling ₹4,526 crore. Granules India's enterprise value is ₹11,944 crore, with an EVEBITDA of 14.3 and a CMP/FCF of 76.8. Overall, Granules India demonstrates solid financial performance and stability in the pharmaceutical industry.